Ramoplanin

[Guest]

Check out this web site: <!-- BBCode auto-link start --><a href="http://www.biospace.com/navigate/search.cfm" target="_blank">www.biospace.com/navigate/search.cfm</a><!-- BBCode auto-link end --> !!!!!! <BR> <BR>Not only are they working on a new drug for C-Diff, but is supposed to be 10 times as potent as Vancocin!!! Apparently this drug has yielded encouraging preliminary results. Phase III of this study is to commence by the end of the year! Do a search on Ramoplanin! Also check this web site: <!-- BBCode auto-link start --><a href="http://www.eurekalert.org/pub_realeases/2002-05/uopm-rba052102.php." target="_blank">www.eurekalert.org/pub_realeases/2002-05/uopm-rba052102.php.</a><!-- BBCode auto-link end --> It states : "Ramoplanin is more effective than front line antibotics such as vancomycin. <BR> <BR>Also as of 8/25/2004, the FDA has received clearance of a New Test for C-Diff. <BR> <BR>Go to the biospace web site and do a search on news and diseases and type in Clostridium Difficile. I think this will be uplifting and if not immediate encouraging news for all C-Diff sufferers! New drugs and new tests for C-Diff.

[Guest]

Debby, <BR>I posted your info. in FAQ under <!-- BBCode Start --><I>New Treatments for C. diff.</I><!-- BBCode End --> Thanks.

[Bobbie]

CindyM submitted the following info. Sounds promising. Thanks, Cindy.

News Article about Oscient Pharmaceuticals:
http://investors.oscient.com/phoenix.zh ... highlight=

Press release from Oscient Pharm. (manufactuer of Ramoplanin):
http://www.biospace.com/news_rxtarget.a ... etID=39604
(sixth bullet point in the report)

I contacted the FDA and Oscient but didn't obtain any new info. To contact the FDA, see (FAQ-FDA). To contact Oscient:

Oscient Pharmaceuticals
1000 Winter Street, Suite 2200
Waltham, MA 02451
781-398-2300
781-893-9535 (fax)
www.oscient.com

Info. also in Media Reports.

[Marcia]

Marcia posted this. Thx. Marcia. Since we can't post text because of copyright laws, I just posted the hyperlink.

Oscient Pharmaceuticals Acquires Expanded Worldwide Rights to Lead Clinical Candidate Ramoplanin; Key milestone for commencing Phase III program
2/8/2006 8:30:00 AM EST

http://www.businessweek.com/ap/financia ... wn&chan=db